News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytomX Therapeutics, Inc. Presents Data for First-in-Class Jagged Probody™ Program at American Association for Cancer Research-American Association for Cancer Research-EORTC International Conference


10/23/2013 7:02:18 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

CytomX Therapeutics, the Probody™ therapeutics company, today announced the presentation of new data demonstrating preclinical proof of concept of the Company’s Jagged Probody blocking Jagged-dependent Notch signaling for the treatment of cancer. These data were presented for the first time during a poster session today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held Oct. 19-23, 2013, in Boston.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES